By Debdeep Gupta | 12 Dec, 2024
Gland Pharma shares gain 2% on USFDA approval for Phytonadione injectable emulsion
Gland Pharma's share price rose 2 percent in the opening trade on December 12 after the company received approval from the United States Food and Drug Administration (USFDA) for Phytonadione Injectable Emulsion USP, 10 mg/mL single-dose ampules.At 09:21 am, Gland Pharma was quoting at Rs 1,823.70, up Rs 48.35, or 2.72 percent, on the BSE.The product is bioequivalent and therapeutically equivalent ...
Live Comments
INVESTINGPOWER 2023-01-12 20:53:55
definitely it will breach 1400 very soon...
Login & Reply Like(0) Dislike(0) Repost SpamSIMRANTEC 2022-09-10 19:02:27
Bull puts shit....and what else it can give😀
Login & Reply Like(0) Dislike(0) Repost SpamKIYARA 2022-09-09 14:59:54
buy mark my words intraday 2400 tgt 2435.
Login & Reply Like(0) Dislike(0) Repost SpamPreeti 2022-09-01 14:30:29
if the stock closes above 2460 today then dont sell..this will be uptrend upto 3000/-
Login & Reply Like(0) Dislike(0) Repost SpamSunil 2022-07-21 13:36:07
Sell ... sell ... No positive sign seen in near future .. stock is underperformed against benchmark since last 9 months ... sell .... will down ... to 2100 , 2050 ....
Login & Reply Like(0) Dislike(0) Repost SpamWorld_Investor1 2022-07-21 12:33:16
closing will be above 2380 and if it cross then 2410 level will see....
Login & Reply Like(0) Dislike(0) Repost SpamDUDU 2022-07-21 10:41:21
why this gland is down by 2000/- per share from its 52weeks high of 4350/- to 2320/- now. what is wrong with this script. and it is behaving like a third class stock..worst stock ....
Login & Reply Like(0) Dislike(0) Repost SpamINTRADAY01 2022-07-08 19:07:43
banking stock looking week but after some time grow up fastly keep your eyes..
Login & Reply Like(0) Dislike(0) Repost SpamLive_Love_Laugh 2022-07-05 10:22:58
EBITDA margins were impacted by the changes in geographic mix, and higher logistic and utilities cost.
Login & Reply Like(0) Dislike(0) Repost SpamNickName01 2022-06-27 15:41:53
all depends on their june quarter results. If they are good, it may go to 4000 levels.
Login & Reply Like(0) Dislike(0) Repost Spamamateurinvestor1 2022-06-21 11:27:12
Positive Alert for Gland Pharma: CLSA initiated coverage on Glad Pharma with a Buy Rating and a price target of 3450. this is the only listed company majority owned by china.
Login & Reply Like(0) Dislike(0) Repost Spamdeep1985 2021-11-29 20:33:27
Fundamentals, sector news, stock ideas and insights ........v.gd/4x3mcG
Login & Reply Like(0) Dislike(0) Repost Spam